U.S. Markets closed

How The 'Earnings Risk' Led This Highly Rated Medical Stock Into A Deluge

ALLISON GATLIN
How The 'Earnings Risk' Led This Highly Rated Medical Stock Into A Deluge

Genomic Health stock toppled Thursday after the company offered a big beat on fourth-quarter sales, but earnings were mixed. An analyst says investors are nitpicking gross margins.